Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-022984
Filing Date
2021-09-17
Accepted
2021-09-17 14:46:48
Documents
68
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 947035
2 ex21-1.htm EX-21.1 3785
3 ex31-1.htm EX-31.1 17703
4 ex31-2.htm EX-31.2 16481
5 ex32-1.htm EX-32.1 8023
6 audit_001.jpg GRAPHIC 4981
7 aud_002.jpg GRAPHIC 7753
8 aud_003.jpg GRAPHIC 4044
  Complete submission text file 0001493152-21-022984.txt   3983570

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE vicp-20201231.xml EX-101.INS 475967
10 XBRL SCHEMA FILE vicp-20201231.xsd EX-101.SCH 47636
11 XBRL CALCULATION FILE vicp-20201231_cal.xml EX-101.CAL 51862
12 XBRL DEFINITION FILE vicp-20201231_def.xml EX-101.DEF 191620
13 XBRL LABEL FILE vicp-20201231_lab.xml EX-101.LAB 339508
14 XBRL PRESENTATION FILE vicp-20201231_pre.xml EX-101.PRE 278783
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

EIN.: 621153426 | State of Incorp.: FL
Type: 10-K | Act: 34 | File No.: 000-56145 | Film No.: 211260054
SIC: 2834 Pharmaceutical Preparations